West Pharma (WST) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $327.95 +1.35%
Revenue Growth %: +9.5%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +9.5%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q2 EPS of $0.52, $0.05 better than the analyst estimate of $0.47. Revenue for the quarter came in at $368.9 million versus the consensus estimate of $368.6 million.
West Pharmaceutical Services, Inc. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
- Pfizer reaffirms 2026 guidance after CFO transition news
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
